Type 2 Diabetes

Finerenone is a mineralocorticoid receptor antagonist indicated for chronic kidney disease (CKD) with type 2 diabetes. Does the use of insulin affect its performance against kidney and cardiovascular issues?

Researchers investigate the changes in ambulatory blood pressure using the antidiabetic drug in patients with type 2 diabetes and hypertension.

Contrary to previous studies, new research finds SGLT-2i more effective for weight loss than GLP-1 RAs as add-on therapy to Metformin. 

Pediatric patients with T2D have accelerated onset of hypertension, dyslipidemia, kidney disease, nerve disease, and diabetic retinopathy.

Recently completed research examines the effect of consistent cycling on all-cause and cardiovascular mortality.

Investigating whether a low-carb diet can lead to diabetes remission.

How has the pandemic affected the incidence of type 2 diabetes and other conditions such as Hyperosmolar Hyperglycemic Syndrome (HHS) within the younger population?

Major electrocardiogram abnormalities have been found in patients with type 2 diabetes. 

Male, 72 years of age, type 2, insulin-requiring diabetes, also taking SGLT-2. Annual physical. No urinary complaints during the visit. Received annual lab work end of the workday, glucose elevated much higher than the reports. WBC elevated, 1200, no urine culture, but U/A did show cloudy....

Genetic risk scores can help provide insight into the problem of increasing youth-onset type 2 diabetes rates.